Reversible high blood CEA and CA19-9 concentrations in a diabetic patient

Reversible high blood CEA and CA19-9 concentrations in a diabetic patient

Bibliographic Details
Main Authors:	Pei-Chi Chen, Hong-Da Lin
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2012-10-01
Series:	Libyan Journal of Medicine
Online Access:	http://www.libyanjournalofmedicine.net/index.php/ljm/article/view/19572/pdf_1

Similar Items

Evaluating Lung Cancer with Tumor Markers: CEA, CA 19-9 and CA 125
by: Muhammed Emin, et al.
Published: (2021-05-01)

Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
by: Leilani Lakemeyer, et al.
Published: (2021-03-01)

Value of CA19-9, CA125 and CEA combined magnetic resonance imaging in the diagnosis of pancreatic cancer
by: Ying Huang, et al.
Published: (2018-02-01)

Raised CA19–9 and CEA have prognostic relevance in gallbladder carcinoma
by: Ashish Sachan, et al.
Published: (2020-08-01)

Metastatic prostate cancer with elevated serum levels of CEA and CA19-9
by: Guang-Dar Juang, et al.
Published: (2014-03-01)

CEA, CA19-9 & A-FP as tumor markers for colorectal carcinoma
by: Ansam A. AL-Bayatti, et al.
Published: (2006-04-01)

The effect of glycemic control on CEA, CA 19-9, amylase and lipase levels
by: Ata Naim, et al.
Published: (2014-09-01)

The dynamics of the serum concentration of CEA, CA15-3 and CA19-9 and survival in patients treated for advanced breast and colorectal cancer. The determination of the prognostic correlates of changes in tumour markers CEA, CA15-3 and CA19-9 during chemotherapy treatment for advanced breast and colorectal cancer.
by: Barker, Laura C.
Published: (2010)

Clinical Significance of Preoperative Serum CEA, CA125, and CA19-9 Levels in Predicting the Resectability of Cholangiocarcinoma
by: Tianyi Fang, et al.
Published: (2019-01-01)

Diagnostic and prognostic value of CEA, CA19–9, AFP and CA125 for early gastric cancer
by: Fan Feng, et al.
Published: (2017-11-01)

A systematic review on CA19.9, CEA and amylase in pancreatic cystic lesions
by: João Artur Ferreira Freitas Coimbra
Published: (2019)

Prognostic value of serum CEA and CA19-9 levels in pancreatic ductal adenocarcinoma
by: Abdulrahman, O., et al.
Published: (2022)

Clinical importance of serum CEA and CA-19-9 levels in oesophagogastric junction adenocarcinomas
by: Ozlem Sert, et al.
Published: (2020-12-01)

Clinical Significance and Prognostic Value of CA72-4 Compared with CEA and CA19-9 in Patients with Gastric Cancer
by: M. Ychou, et al.
Published: (2000-01-01)

Comparison of CYFRA 21-1, CEA, CA 19-9 and CA 72-4 levels in gastric cancer
by: Gökhan Çakırca, et al.
Published: (2013-01-01)

Carcinoembryonic Antigen (CEA) and CA 19-9 Levels in Patients Attended at Lerd-Sin Hospital, Bangkok
by: Tasanee Suwannayod
Published: (2015-02-01)

Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C
by: Mehdi ASSMAR, et al.
Published: (2016-12-01)

Plasma microRNA Levels Combined with CEA and CA19-9 in the Follow-Up of Colorectal Cancer Patients
by: Martin Pesta, et al.
Published: (2019-06-01)

Serum Biomarkers AFP, CEA and CA19-9 Combined Detection for Early Diagnosis of Hepatocellular Carcinoma
by: Muhammad Ibrahim Alhadi EDOO, et al.
Published: (2019-02-01)

Value of combined detection of AFP, CA19-9, and CEA in early diagnosis of primary liver cancer
by: LI Jiayan, et al.
Published: (2017-07-01)

Levels of CEA and Ca 19 - 9 in the sera and peritoneal cavity in patients with gastric and pancreatic cancers Níveis de CEA e Ca 19 - 9 em soro e cavidade peritoneal em pacientes com câncer do estômago e pâncreas
by: David Hoskovec, et al.
Published: (2012-06-01)

Detection of pancreas cancer markers CEA and CA19-9 antigen by AlGaN/GaN high electron mobility transistor biosensor
by: Pei-Hsien Chen, et al.
Published: (2017)

Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer
by: Yanfeng Gao, et al.
Published: (2018-02-01)

Menstrual Cycle Dependent Variability for Serum Tumor Markers CEA, AFP, CA 19-9, CA 125 and CA 15-3 in Healthy Women
by: Ayşe Binnur Erbağci, et al.
Published: (1999-01-01)

Prognostic Value of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 19-9 (CA 19-9) in Gallbladder Cancer; 65 IU/mL of CA 19-9 Is the New Cut-Off Value for Prognosis
by: Myongjin Kim, et al.
Published: (2021-03-01)

Effects of laparoscopic operation combined neoadjuvant chemotherapy on serum levels of CEA, CA242, CA19-9, CA724, ICAM-1 and VCAM-1 in patients with colorectal carcinoma
by: Wen-Jie Xie, et al.
Published: (2017-08-01)

CA125, CEA, CA19-9, and Heteroploid Cells in Ascites Fluid May Help Diagnose Peritoneal Carcinomatosis in Patients with Gastrointestinal and Ovarian Malignancies
by: Deng L, et al.
Published: (2020-10-01)

Detection of Helicobacter Pylori IgG and IgA , Serum Biomarkers CA19-9 and CEA in Patients with Gastrointestinal Diseases
by: Shurooq R. Kadhim, et al.
Published: (2017-03-01)

Fusion Expression and Affinity Identification of Two scFvs Against CEA or CA19-9 in HEK293 Cells
by: LU Wenbin, et al.
Published: (2019-01-01)

Comparative study of CEA and CA19-9 in esophageal, gastric and colon cancers individually and in combination (ROC curve analysis)
by: Bhawna Bagaria, et al.
Published: (2013-09-01)

Highly Correlated Recurrence Prognosis in Patients with Metastatic Colorectal Cancer by Synergistic Consideration of Circulating Tumor Cells/Microemboli and Tumor Markers CEA/CA19-9
by: Hsueh-Yao Chu, et al.
Published: (2021-05-01)

Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers
by: Ramona C Dolscheid-Pommerich, et al.
Published: (2017-10-01)

Effect of paclitaxel liposome combined with nedaplatin on serum HE4, CA125, CA19-9, AFP, CEA and T lymphocyte subsets in patients with advanced ovarian cancer
by: Su-Yu Zhu, et al.
Published: (2016-08-01)

Palliative Gastrectomy Prolongs Survival of Metastatic Gastric Cancer Patients with Normal Preoperative CEA or CA19-9 Values: A Retrospective Cohort Study
by: Chang-Fang Chiu, et al.
Published: (2016-01-01)

Níveis séricos pré-operatórios dos marcadores CEA e CA19-9 e imunoexpressão tecidual do marcador CA19-9 no carcinoma colorretal: relação com os aspectos morfológicos da neoplasia
by: José Roberto Martins de Souza, et al.

A rare case of PSA-negative metastasized prostate cancer to the stomach with serum CEA and CA19-9 elevation: a case report
by: Koji Shindo, et al.
Published: (2020-12-01)

Combination of preoperative CEA and CA19-9 improves prediction outcomes in patients with resectable pancreatic adenocarcinoma: results from a large follow-up cohort
by: Zhou G, et al.
Published: (2017-02-01)

Effect of oxaliplatin combined with capeeitabine as chemotherapy on serum CA125, CEA, TPS, Cyfra21-1, CA19-9 and T lymphocyte subsets of post-operative patients with advanced gastric carcinoma
by: Feng Deng, et al.
Published: (2016-08-01)

Clinical analysis of four serum tumor markers in 458 patients with ovarian tumors: diagnostic value of the combined use of HE4, CA125, CA19-9, and CEA in ovarian tumors
by: Chen F, et al.
Published: (2018-05-01)

Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer
by: Kaisa Lehtomäki, et al.
Published: (2021-08-01)